These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19679423)

  • 1. Current evidence and clinical implications of aspirin resistance.
    Kasotakis G; Pipinos II; Lynch TG
    J Vasc Surg; 2009 Dec; 50(6):1500-10. PubMed ID: 19679423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin resistance and atherothrombotic disease.
    Mason PJ; Jacobs AK; Freedman JE
    J Am Coll Cardiol; 2005 Sep; 46(6):986-93. PubMed ID: 16168280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin resistance: current concepts.
    Mason PJ; Freedman JE; Jacobs AK
    Rev Cardiovasc Med; 2004; 5(3):156-63. PubMed ID: 15346099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin resistance: focus on clinical endpoints.
    Pusch G; Feher G; Kotai K; Tibold A; Gasztonyi B; Feher A; Papp E; Lupkovics G; Szapary L
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):475-84. PubMed ID: 19034037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL; Topol EJ;
    Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical appraisal of the phenomenon of aspirin resistance.
    Svenstrup Poulsen T; Kristensen SR; Atar D; Mickley H
    Cardiology; 2005; 104(2):83-91. PubMed ID: 16020925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
    Gasparyan AY; Watson T; Lip GY
    J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
    Poredos P; Jezovnik MK
    Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A current problem in atherothrombotic diseases--aspirin resistance: definition, mechanisms, determination with laboratory tests and clinical implications].
    Pamukçu B; Oflaz H; Nişanci Y
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():20-6. PubMed ID: 18160363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preventive and therapeutic impact of antiplatelet agents: past and present.
    Gensini GF; Conti AA
    Minerva Med; 2009 Apr; 100(2):133-6. PubMed ID: 19390498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet drugs in cardiovascular diseases.
    Weston C; Rao U
    Int J Clin Pract; 2003 Dec; 57(10):898-905. PubMed ID: 14712893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin resistance in stroke: 2004.
    Sztriha LK; Sas K; Vecsei L
    J Neurol Sci; 2005 Mar; 229-230():163-9. PubMed ID: 15760636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin resistance: effect of clinical, biochemical and genetic factors.
    Fitzgerald R; Pirmohamed M
    Pharmacol Ther; 2011 May; 130(2):213-25. PubMed ID: 21295071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.